Mobocitinib (Exkivity)

Ingredients: Mobocertinib
Dosage Form: Capsules
Innovator’s Brand Name: Exkivity
Generic Brand Name: Mobonib
Generic Manufacturer: Ziska Pharma

Indications:
Mobocertinib is indicated for the treatment of adult patients with locally advanced or metastatic non‑small cell lung cancer harboring epidermal growth factor receptor (EGFR) exon 20 insertion mutations.

Dosage and Administration:
The recommended dose is 160 mg orally once daily, with or without food; swallow capsules whole—do not crush. If a dose is missed, follow your healthcare provider’s instructions.

Adverse Reactions:
Common adverse reactions include diarrhea, rash, nausea, vomiting, and paronychia; interstitial lung disease may occur in some patients.

Storage:
Store in a cool, dry place below 25 °C, protected from light, and keep out of reach of children.

Package Insert (Prescribing Information):

Download Link